Detailed information for compound 884011

Basic information

Technical information
  • TDR Targets ID: 884011
  • Name: N-[(4-butoxyphenyl)methylideneamino]-2-[(3,5- dioxo-2H-1,2,4-triazin-6-yl)sulfanyl]acetamid e
  • MW: 377.418 | Formula: C16H19N5O4S
  • H donors: 3 H acceptors: 6 LogP: 2.2 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCOc1ccc(cc1)C=NNC(=O)CSc1nnc(nc1O)O
  • InChi: 1S/C16H19N5O4S/c1-2-3-8-25-12-6-4-11(5-7-12)9-17-19-13(22)10-26-15-14(23)18-16(24)21-20-15/h4-7,9H,2-3,8,10H2,1H3,(H,19,22)(H2,18,21,23,24)/b17-9+
  • InChiKey: KNLPNIDPOFSBIJ-RQZCQDPDSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-[(4-butoxyphenyl)methyleneamino]-2-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)sulfanyl]acetamide
  • N-[(4-butoxyphenyl)methyleneamino]-2-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)thio]acetamide
  • N-[(4-butoxybenzylidene)amino]-2-[(3,5-diketo-2H-1,2,4-triazin-6-yl)thio]acetamide
  • N-[(4-butoxyphenyl)methylideneamino]-2-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)sulfanyl]ethanamide
  • ST5323362

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major mitogen-activated protein kinase, putative,map kinase-like protein 0.0019 0 0.5
Trichomonas vaginalis CMGC family protein kinase 0.1305 1 1
Leishmania major serine/threonine kinase-like protein, putative 0.0019 0 0.5
Echinococcus granulosus CDC7 cell division cycle 7 0.1305 1 1
Loa Loa (eye worm) hypothetical protein 0.0267 0.1926 0.1926
Trypanosoma cruzi serine/threonine protein kinase, putative 0.0019 0 0.5
Brugia malayi cyclin-dependent kinase 9 0.0058 0.0301 0.0301
Trichomonas vaginalis CMGC family protein kinase 0.1305 1 1
Trichomonas vaginalis CMGC family protein kinase 0.1305 1 1
Echinococcus multilocularis cyclin dependent kinase 9 0.0058 0.0301 0.0301
Plasmodium falciparum MO15-related protein kinase 0.0019 0 0.5
Onchocerca volvulus 0.1305 1 0.5
Entamoeba histolytica protein kinase domain containing protein 0.0058 0.0301 1
Onchocerca volvulus 0.1305 1 0.5
Loa Loa (eye worm) CMGC/CDK/CDK9 protein kinase 0.0058 0.0301 0.0301
Schistosoma mansoni serine/threonine protein kinase 0.1305 1 1
Echinococcus multilocularis cyclin dependent kinase 9 0.0066 0.0365 0.0365
Echinococcus granulosus cyclin dependent kinase 9 0.0058 0.0301 0.0301
Echinococcus granulosus cyclin dependent kinase 9 0.0066 0.0365 0.0365
Schistosoma mansoni serine/threonine protein kinase 0.0058 0.0301 0.0301
Plasmodium vivax cyclin dependent kinase 7 (cdk7), putative 0.0019 0 0.5
Schistosoma mansoni kinase 0.0058 0.0301 0.0301
Giardia lamblia Kinase, CDC7 0.1305 1 1
Plasmodium vivax serine/threonine protein kinase KIN, putative 0.0019 0 0.5
Trypanosoma brucei Mitogen-activated protein kinase 10, putative 0.0019 0 0.5
Trypanosoma cruzi Mitogen-activated protein kinase 10, putative 0.0019 0 0.5
Echinococcus multilocularis CDC7 cell division cycle 7 0.1305 1 1
Trypanosoma brucei protein kinase, putative 0.0019 0 0.5
Trypanosoma cruzi Mitogen-activated protein kinase 10, putative 0.0019 0 0.5
Loa Loa (eye worm) CDC7 protein kinase 0.1305 1 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.